$PNBK
PATRIOT NATIONAL BANCORP INC Stock $pnbk

$pnbk Overview Financials Valuation SEC Filings Company Website

2020 Q3 Form 10-Q Financial Statement

#000143774920023808 Filed on November 13, 2020

Income Statement

Concept	2020 Q3	2020 Q2	2019 Q3
Revenue	$9.031M	$9.603M	$11.01M
YoY Change	-17.99%	-13.44%	7.5%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$380.0K	$410.0K	$430.0K
YoY Change	-11.63%	-2.38%	7.5%
% of Gross Profit
Operating Expenses
YoY Change
Operating Profit
YoY Change
Interest Expense	$3.125M	$3.916M	$4.769M
YoY Change	-34.47%	-12.47%	37.99%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income	-$93.00K	-$1.724M	$35.00K
YoY Change	-365.71%	-24.62%	-96.65%
Income Tax	-$6.000K	-$446.0K	$8.000K
% Of Pretax Income			22.86%
Net Earnings	-$87.00K	-$1.278M	$27.00K
YoY Change	-422.22%	-22.78%	-96.49%
Net Earnings / Revenue	-0.96%	-13.31%	0.25%
Basic Earnings Per Share	-$0.02	-$0.32	$0.01
Diluted Earnings Per Share	-$0.02	-$0.32	$0.01
COMMON SHARES
Basic Shares Outstanding	3.936M	3.935M	3.923M
Diluted Shares Outstanding	3.936M	3.935M	3.923M

Balance Sheet

Concept	2020 Q3	2020 Q2	2019 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents	$49.64M	$65.90M	$50.00M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment	$33.63M	$33.96M	$34.88M
YoY Change	-3.59%	-3.65%	-1.7%
Goodwill	$1.107M	$1.107M	$1.107M
YoY Change	0.0%	0.0%	-43.06%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$12.10M	$12.20M	$11.50M
YoY Change	5.22%	9.91%	5.5%
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets	$922.9M	$979.5M	$972.0M
YoY Change	-5.05%	0.18%	6.19%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses	$7.600M	$7.700M	$8.600M
YoY Change	-11.63%	0.0%	104.76%
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$7.600M	$7.700M	$8.600M
YoY Change	-11.63%	0.0%	104.76%
LONG-TERM LIABILITIES
Long-Term Debt	$30.80M	$30.90M	$30.90M
YoY Change	-0.32%	0.0%	-0.32%
Other Long-Term Liabilities	$2.500M	$3.800M	$2.200M
YoY Change	13.64%	18.75%	29.41%
Total Long-Term Liabilities	$33.30M	$34.70M	$33.10M
YoY Change	0.6%	1.76%	1.22%
TOTAL LIABILITIES
Total Short-Term Liabilities	$7.600M	$7.700M	$8.600M
Total Long-Term Liabilities	$33.30M	$34.70M	$33.10M
Total Liabilities	$858.4M	$915.4M	$903.8M
YoY Change	-5.02%	0.65%	6.79%
SHAREHOLDERS EQUITY
Retained Earnings	-$41.21M	-$41.12M	-$37.22M
YoY Change	10.71%	10.52%	3.17%
Common Stock	$106.3M	$106.3M	$106.1M
YoY Change	0.16%	-0.92%	-0.9%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$64.54M	$64.17M	$68.18M
YoY Change
Total Liabilities & Shareholders Equity	$922.9M	$979.5M	$972.0M
YoY Change	-5.05%	0.18%	6.19%

Cashflow Statement

Concept	2020 Q3	2020 Q2	2019 Q3
OPERATING ACTIVITIES
Net Income	-$87.00K	-$1.278M	$27.00K
YoY Change	-422.22%	-22.78%	-96.49%
Depreciation, Depletion And Amortization	$380.0K	$410.0K	$430.0K
YoY Change	-11.63%	-2.38%	7.5%
Cash From Operating Activities	$3.570M	-$10.00K	$1.550M
YoY Change	130.32%	-99.71%	53.47%
INVESTING ACTIVITIES
Capital Expenditures	-$40.00K	-$120.0K	-$110.0K
YoY Change	-63.64%	-70.73%	-31.25%
Acquisitions
YoY Change
Other Investing Activities	$37.20M	$32.91M	$4.090M
YoY Change	809.54%	-218.98%	-118.57%
Cash From Investing Activities	$37.16M	$32.79M	$3.980M
YoY Change	833.67%	-216.86%	-117.94%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-56.99M	-19.04M	-6.650M
YoY Change	756.99%	-173.32%	-56.34%
NET CHANGE
Cash From Operating Activities	3.570M	-10.00K	1.550M
Cash From Investing Activities	37.16M	32.79M	3.980M
Cash From Financing Activities	-56.99M	-19.04M	-6.650M
Net Change In Cash	-16.26M	13.74M	-1.120M
YoY Change	1351.79%	-348.91%	-96.92%
FREE CASH FLOW
Cash From Operating Activities	$3.570M	-$10.00K	$1.550M
Capital Expenditures	-$40.00K	-$120.0K	-$110.0K
Free Cash Flow	$3.610M	$110.0K	$1.660M
YoY Change	117.47%	-103.64%	41.88%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2020Q3	pnbk	Accrued Interest And Dividends Receivable AccruedInterestAndDividendsReceivable	6834000
CY2019Q4	pnbk	Accrued Interest And Dividends Receivable AccruedInterestAndDividendsReceivable	3603000
	pnbk	Amortization And Accretion Of Purchase Loan Premiums And Discounts Net AmortizationAndAccretionOfPurchaseLoanPremiumsAndDiscountsNet	-589000
	pnbk	Amortization And Accretion Of Purchase Loan Premiums And Discounts Net AmortizationAndAccretionOfPurchaseLoanPremiumsAndDiscountsNet	-702000
	pnbk	Amortization Of Servicing Assets Of Sold Loans AmortizationOfServicingAssetsOfSoldLoans	15000
	pnbk	Amortization Of Servicing Assets Of Sold Loans AmortizationOfServicingAssetsOfSoldLoans	10000
CY2020Q3	pnbk	Availableforsale Securities Debt Maturities Year One Through Five Amortized Cost Basis AvailableforsaleSecuritiesDebtMaturitiesYearOneThroughFiveAmortizedCostBasis	7438000
CY2019Q4	pnbk	Availableforsale Securities Debt Maturities Year One Through Five Amortized Cost Basis AvailableforsaleSecuritiesDebtMaturitiesYearOneThroughFiveAmortizedCostBasis	7823000
CY2020Q3	pnbk	Availableforsale Securities Debt Maturities Year One Through Five Fair Value AvailableforsaleSecuritiesDebtMaturitiesYearOneThroughFiveFairValue	7576000
CY2019Q4	pnbk	Availableforsale Securities Debt Maturities Year One Through Five Fair Value AvailableforsaleSecuritiesDebtMaturitiesYearOneThroughFiveFairValue	7961000
CY2020Q3	pnbk	Banks Reserve Based On Analysis In Unfunded Commitments BanksReserveBasedOnAnalysisInUnfundedCommitments	8000
CY2019Q4	pnbk	Banks Reserve Based On Analysis In Unfunded Commitments BanksReserveBasedOnAnalysisInUnfundedCommitments	8000
CY2020Q3	pnbk	Capital Conservation Buffer CapitalConservationBuffer	0.025
	pnbk	Capitalized Servicing Assets CapitalizedServicingAssets	115000
	pnbk	Capitalized Servicing Assets CapitalizedServicingAssets	169000
CY2020Q3	pnbk	Certain Loans Acquired In Transfer Not Accounted For As Debt Securities Accretable Yield Other Changes CertainLoansAcquiredInTransferNotAccountedForAsDebtSecuritiesAccretableYieldOtherChanges
CY2019Q3	pnbk	Certain Loans Acquired In Transfer Not Accounted For As Debt Securities Accretable Yield Other Changes CertainLoansAcquiredInTransferNotAccountedForAsDebtSecuritiesAccretableYieldOtherChanges	141000
	pnbk	Certain Loans Acquired In Transfer Not Accounted For As Debt Securities Accretable Yield Other Changes CertainLoansAcquiredInTransferNotAccountedForAsDebtSecuritiesAccretableYieldOtherChanges	45000
	pnbk	Certain Loans Acquired In Transfer Not Accounted For As Debt Securities Accretable Yield Other Changes CertainLoansAcquiredInTransferNotAccountedForAsDebtSecuritiesAccretableYieldOtherChanges	698000
CY2020Q3	pnbk	Commitments To Extend Credit CommitmentsToExtendCredit	150357000
CY2019Q4	pnbk	Commitments To Extend Credit CommitmentsToExtendCredit	145065000
CY2020Q3	pnbk	Common Equity Tier1 Capital Required For Capital Adequacy To Risk Weighted Assets CommonEquityTier1CapitalRequiredForCapitalAdequacyToRiskWeightedAssets	0.065
CY2019Q1	pnbk	Common Equity Tier1 Capital Required For Capital Adequacy To Risk Weighted Assets CommonEquityTier1CapitalRequiredForCapitalAdequacyToRiskWeightedAssets	0.07
CY2019Q3	pnbk	Community Bank Tier One Leverage Capital Required For Capital Adequacy CommunityBankTierOneLeverageCapitalRequiredForCapitalAdequacy	10000000000
CY2019Q3	pnbk	Community Bank Tier One Leverage Ratio CommunityBankTierOneLeverageRatio	0.09
CY2020Q3	pnbk	Fees And Service Charges FeesAndServiceCharges	73000
CY2019Q3	pnbk	Fees And Service Charges FeesAndServiceCharges	123000
	pnbk	Fees And Service Charges FeesAndServiceCharges	253000
	pnbk	Fees And Service Charges FeesAndServiceCharges	366000
CY2020Q3	pnbk	Financing Receivable Loans Remaining On Deferment FinancingReceivableLoansRemainingOnDeferment	157700000
CY2020Q3	pnbk	Financing Receivable Principal And Interest Deferred Payments FinancingReceivablePrincipalAndInterestDeferredPayments	244400000
CY2020Q3	pnbk	Financing Receivable Troubled Debt Restructuring Number Of Contracts FinancingReceivableTroubledDebtRestructuringNumberOfContracts	9
CY2019Q4	pnbk	Financing Receivable Troubled Debt Restructuring Number Of Contracts FinancingReceivableTroubledDebtRestructuringNumberOfContracts	6
	pnbk	Gain Loss On Sale Of Sba Loans Held For Sale Net GainLossOnSaleOfSBALoansHeldForSaleNet	464000
	pnbk	Gain Loss On Sale Of Sba Loans Held For Sale Net GainLossOnSaleOfSBALoansHeldForSaleNet	864000
CY2020Q3	pnbk	General Insurance Income Expense GeneralInsuranceIncomeExpense	67000
CY2019Q3	pnbk	General Insurance Income Expense GeneralInsuranceIncomeExpense	65000
	pnbk	General Insurance Income Expense GeneralInsuranceIncomeExpense	215000
	pnbk	General Insurance Income Expense GeneralInsuranceIncomeExpense	160000
CY2020Q3	pnbk	Impaired Financing Receivable Nonperforming Loans Discount Of Appraisal Value Selling Costs Percent ImpairedFinancingReceivableNonperformingLoansDiscountOfAppraisalValueSellingCostsPercent	0.08
CY2020Q3	pnbk	Impaired Financing Receivable Nonperforming Loans Discount To Appraisal Value Percent ImpairedFinancingReceivableNonperformingLoansDiscountToAppraisalValuePercent	0.12
CY2020Q3	pnbk	Interest Expense Notes Payable InterestExpenseNotesPayable	5000
CY2019Q3	pnbk	Interest Expense Notes Payable InterestExpenseNotesPayable	6000
	pnbk	Interest Expense Notes Payable InterestExpenseNotesPayable	15000
	pnbk	Interest Expense Notes Payable InterestExpenseNotesPayable	20000
CY2020Q3	pnbk	Interest Expense Senior Debt InterestExpenseSeniorDebt	229000
CY2019Q3	pnbk	Interest Expense Senior Debt InterestExpenseSeniorDebt	229000
	pnbk	Interest Expense Senior Debt InterestExpenseSeniorDebt	686000
	pnbk	Interest Expense Senior Debt InterestExpenseSeniorDebt	686000
CY2020Q3	pnbk	Loan Application Inspection Processing Fees LoanApplicationInspectionProcessingFees	54000
CY2019Q3	pnbk	Loan Application Inspection Processing Fees LoanApplicationInspectionProcessingFees	32000
	pnbk	Loan Application Inspection Processing Fees LoanApplicationInspectionProcessingFees	147000
	pnbk	Loan Application Inspection Processing Fees LoanApplicationInspectionProcessingFees	74000
	pnbk	Loans Receivable Term To Reset To Fhlb Rate LoansReceivableTermToResetToFhlbRate	P5Y
CY2020Q3	pnbk	Loans Serviced By Entity But Owned By A Third Party LoansServicedByEntityButOwnedByAThirdParty	18600000
CY2019Q4	pnbk	Loans Serviced By Entity But Owned By A Third Party LoansServicedByEntityButOwnedByAThirdParty	13600000
CY2020Q3	pnbk	Material And Communications MaterialAndCommunications	118000
CY2019Q3	pnbk	Material And Communications MaterialAndCommunications	118000
	pnbk	Material And Communications MaterialAndCommunications	371000
	pnbk	Material And Communications MaterialAndCommunications	383000
	pnbk	Maximum Period For Charged Off Of Consumer Installment Loans MaximumPeriodForChargedOffOfConsumerInstallmentLoans	P180D
	pnbk	Maximum Period Of Credit Extension Of Construction Loans MaximumPeriodOfCreditExtensionOfConstructionLoans	P1Y180D
	pnbk	Non Cash Transactions Accrued Liability For Oreo Sale NonCashTransactionsAccruedLiabilityForOREOSale
	pnbk	Non Cash Transactions Accrued Liability For Oreo Sale NonCashTransactionsAccruedLiabilityForOREOSale	86000
	pnbk	Noncash Activity Increase In Operating Lease Liabilities NoncashActivityIncreaseInOperatingLeaseLiabilities	-57000
	pnbk	Noncash Activity Increase In Operating Lease Liabilities NoncashActivityIncreaseInOperatingLeaseLiabilities	-3364000
	pnbk	Noncash Activity Increase In Operating Lease Rightofuse Assets NoncashActivityIncreaseInOperatingLeaseRightofuseAssets	57000
	pnbk	Noncash Activity Increase In Operating Lease Rightofuse Assets NoncashActivityIncreaseInOperatingLeaseRightofuseAssets	3267000
	pnbk	Noncash Or Part Noncash Acquisition Contingent Liabilities Assumed NoncashOrPartNoncashAcquisitionContingentLiabilitiesAssumed
	pnbk	Noncash Or Part Noncash Acquisition Contingent Liabilities Assumed NoncashOrPartNoncashAcquisitionContingentLiabilitiesAssumed	621000
CY2020Q3	pnbk	Number Of Availableforsale Securities NumberOfAvailableforsaleSecurities	34
CY2019Q4	pnbk	Number Of Availableforsale Securities NumberOfAvailableforsaleSecurities	27
CY2020Q3	pnbk	Number Of Impaired Loans NumberOfImpairedLoans	30
CY2019Q4	pnbk	Number Of Impaired Loans NumberOfImpairedLoans	27
	pnbk	Payments For Origination Of Sba Loans Held For Sale PaymentsForOriginationOfSBALoansHeldForSale	1694000
	pnbk	Payments For Origination Of Sba Loans Held For Sale PaymentsForOriginationOfSBALoansHeldForSale	15208000
	pnbk	Payments To Acquire Prepaid Debit Card Deposit PaymentsToAcquirePrepaidDebitCardDeposit	-49998000
	pnbk	Payments To Acquire Prepaid Debit Card Deposit PaymentsToAcquirePrepaidDebitCardDeposit
CY2020Q3	pnbk	Payments To Acquire Prepaid Debit Card Deposits PaymentsToAcquirePrepaidDebitCardDeposits	50000000
	pnbk	Period For Charged Off Of Closeend Credits PeriodForChargedOffOfCloseendCredits	P120D
	pnbk	Period For Charged Off Of Openend Credits PeriodForChargedOffOfOpenendCredits	P180D
CY2020Q3	pnbk	Prepaid Debit Card Deposits PrepaidDebitCardDeposits	60000000
	pnbk	Proceeds From Payments For Originated Loans Receivable Net ProceedsFromPaymentsForOriginatedLoansReceivableNet	95464000
	pnbk	Proceeds From Payments For Originated Loans Receivable Net ProceedsFromPaymentsForOriginatedLoansReceivableNet	4552000
	pnbk	Proceeds From Principal Repayments On Debt Securities Available For Sale ProceedsFromPrincipalRepaymentsOnDebtSecuritiesAvailableForSale	6674000
	pnbk	Proceeds From Principal Repayments On Debt Securities Available For Sale ProceedsFromPrincipalRepaymentsOnDebtSecuritiesAvailableForSale	2588000
CY2020Q3	pnbk	Project Expenses ProjectExpenses	6000
CY2019Q3	pnbk	Project Expenses ProjectExpenses	212000
	pnbk	Project Expenses ProjectExpenses	154000
	pnbk	Project Expenses ProjectExpenses	277000
	pnbk	Refund Of Payment For Escrow Deposit Related To Acquisition Activity RefundOfPaymentForEscrowDepositRelatedToAcquisitionActivity
	pnbk	Refund Of Payment For Escrow Deposit Related To Acquisition Activity RefundOfPaymentForEscrowDepositRelatedToAcquisitionActivity	500000
CY2020Q3	pnbk	Regulatory Assessments RegulatoryAssessments	355000
CY2019Q3	pnbk	Regulatory Assessments RegulatoryAssessments	152000
	pnbk	Regulatory Assessments RegulatoryAssessments	1159000
	pnbk	Regulatory Assessments RegulatoryAssessments	862000
CY2019Q1	pnbk	Tier One Risk Based Capital Required To Be Well Capitalized To Risk Weighted Assets With Capital Buffer TierOneRiskBasedCapitalRequiredToBeWellCapitalizedToRiskWeightedAssetsWithCapitalBuffer	0.085
CY2020Q3	pnbk	Time Deposits Below Fdic Insurance Limit TimeDepositsBelowFDICInsuranceLimit	160610000
CY2019Q4	pnbk	Time Deposits Below Fdic Insurance Limit TimeDepositsBelowFDICInsuranceLimit	193942000
CY2020Q3	pnbk	Unrealized Holding Losses Depreciation Percentage From Amortized Cost UnrealizedHoldingLossesDepreciationPercentageFromAmortizedCost	0.037
CY2019Q4	pnbk	Unrealized Holding Losses Depreciation Percentage From Amortized Cost UnrealizedHoldingLossesDepreciationPercentageFromAmortizedCost	0.037
	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	-168000
	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	20000
CY2020Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-546000
CY2019Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-403000
CY2020Q3	us-gaap	Advance Payments By Borrowers For Taxes And Insurance AdvancePaymentsByBorrowersForTaxesAndInsurance	2492000
CY2019Q4	us-gaap	Advance Payments By Borrowers For Taxes And Insurance AdvancePaymentsByBorrowersForTaxesAndInsurance	3681000
CY2020Q3	us-gaap	Allowance For Doubtful Accounts Premiums And Other Receivables AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables	11171000
CY2019Q4	us-gaap	Allowance For Doubtful Accounts Premiums And Other Receivables AllowanceForDoubtfulAccountsPremiumsAndOtherReceivables	10115000
CY2020Q3	us-gaap	Allowance For Loan And Lease Loss Recovery Of Bad Debts AllowanceForLoanAndLeaseLossRecoveryOfBadDebts	13000
CY2019Q3	us-gaap	Allowance For Loan And Lease Loss Recovery Of Bad Debts AllowanceForLoanAndLeaseLossRecoveryOfBadDebts	129000
	us-gaap	Allowance For Loan And Lease Loss Recovery Of Bad Debts AllowanceForLoanAndLeaseLossRecoveryOfBadDebts	67000
	us-gaap	Allowance For Loan And Lease Loss Recovery Of Bad Debts AllowanceForLoanAndLeaseLossRecoveryOfBadDebts	183000
CY2020Q3	us-gaap	Allowance For Loan And Lease Losses Write Offs AllowanceForLoanAndLeaseLossesWriteOffs	75000
CY2019Q3	us-gaap	Allowance For Loan And Lease Losses Write Offs AllowanceForLoanAndLeaseLossesWriteOffs	282000
	us-gaap	Allowance For Loan And Lease Losses Write Offs AllowanceForLoanAndLeaseLossesWriteOffs	810000
	us-gaap	Allowance For Loan And Lease Losses Write Offs AllowanceForLoanAndLeaseLossesWriteOffs	2589000
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	84000
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	84000
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	56000
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	56000
CY2020Q3	us-gaap	Assets Assets	922929000
CY2019Q4	us-gaap	Assets Assets	979836000
CY2020Q3	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	382000
CY2019Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	405000
CY2020Q3	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	1118000
CY2019Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	948000
CY2020Q3	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	48559000
CY2019Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	48860000
CY2020Q3	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost	30588000
CY2019Q4	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost	30226000
CY2020Q3	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue	29628000
CY2019Q4	us-gaap	Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue	29497000
CY2020Q3	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost	10533000
CY2019Q4	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost	10811000
CY2020Q3	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue	10619000
CY2019Q4	us-gaap	Available For Sale Securities Debt Maturities After Ten Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue	10859000
CY2020Q3	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	47823000
CY2019Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	48317000
	us-gaap	Basis Of Accounting BasisOfAccounting	<div style="display: inline; font-family: times new roman; font-size: 10pt"><table border="0" cellpadding="0" cellspacing="0" style="; text-indent: 0px; min-width: 700px;"> <tr style="vertical-align: top;"> <td style="width: 54pt;"> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">Note <div style="display: inline; font-style: italic; font: inherit;">1.</div></div></div> </td> <td> <div style=" margin: 0pt; text-align: left; font-family: "Times New Roman", Times, serif; font-size: 10pt;"><div style="display: inline; font-weight: bold;">Basis of Financial Statement Presentation</div></div> </td> </tr> </table> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">The accompanying unaudited condensed consolidated financial statements of Patriot National Bancorp, Inc. (the “Company”) and its wholly-owned subsidiaries Patriot Bank, N.A. (the “Bank”) , Patriot National Statutory Trust I and PinPat Acquisition Corporation (collectively, “Patriot”), have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). Accordingly, certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America (“US GAAP”) have been omitted. The accompanying unaudited interim condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto included on the Annual Report on Form <div style="display: inline; font-style: italic; font: inherit;">10</div>-K for the year ended <div style="display: inline; font-style: italic; font: inherit;"> December 31, 2019.</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">The consolidated balance sheet at <div style="display: inline; font-style: italic; font: inherit;"> December 31, 2019 </div>presented herein has been derived from the audited consolidated financial statements of the Company at that date, but does <div style="display: inline; font-style: italic; font: inherit;">not</div> include all of the information and footnotes required by US GAAP for complete financial statements.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">The preparation of consolidated financial statements in accordance with US GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses, and to disclose contingent assets and liabilities. Actual results could differ from those estimates. Management has identified accounting for the allowance for loan and lease losses, the analysis and valuation of its investment securities, the valuation of deferred tax assets, the impairment of goodwill, the valuation of derivatives, and the valuation of servicing assets as certain of the Company's more significant accounting policies and estimates, in that they are critical to the presentation of the Company's consolidated financial condition and results of operations. As they concern matters that are inherently uncertain, these estimates require management to make subjective and complex judgments in the preparation of the Company's consolidated financial statements.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><div style="display: inline; text-decoration: underline;">Reclassifications:</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">Certain amounts appearing in the financial statements and notes thereto for prior periods have been reclassified to conform with the current presentation. The reclassifications had <div style="display: inline; font-style: italic; font: inherit;">no</div> effect on net income or stockholders' equity as previously reported.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">The information furnished reflects, in the opinion of management, all normal recurring adjustments necessary for a fair presentation of the results for the interim periods presented. The results of operations for the <div style="display: inline; font-style: italic; font: inherit;">three</div> and <div style="display: inline; font-style: italic; font: inherit;">nine</div> months ended <div style="display: inline; font-style: italic; font: inherit;"> September 30, 2020 </div>are <div style="display: inline; font-style: italic; font: inherit;">not</div> necessarily indicative of the results of operations that <div style="display: inline; font-style: italic; font: inherit;"> may </div>be expected for the remainder of <div style="display: inline; font-style: italic; font: inherit;">2020.</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><div style="display: inline; text-decoration: underline;">COVID-<div style="display: inline; font-style: italic; font: inherit;">19</div> Impact</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">In <div style="display: inline; font-style: italic; font: inherit;"> March 2020, </div>the World Health Organization declared novel coronavirus disease <div style="display: inline; font-style: italic; font: inherit;">2019</div> ("COVID-<div style="display: inline; font-style: italic; font: inherit;">19"</div>) as a global pandemic. The COVID-<div style="display: inline; font-style: italic; font: inherit;">19</div> pandemic has negatively impacted the global and U.S. economies. Many businesses in the U.S., including those in the markets we serve, were required to close, causing a significant increase in unemployment and loss of revenue.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">The consolidated financial statements reflect estimates and assumptions that affect the reported amounts of assets and liabilities, including the amount of the allowance for loan losses. The assumptions and estimates used in the financial statements were impacted by the COVID-<div style="display: inline; font-style: italic; font: inherit;">19</div> pandemic. The COVID-<div style="display: inline; font-style: italic; font: inherit;">19</div> pandemic did have an adverse impact on our earnings and resulted in an increase to the allowance for loan losses when compared to the same period in <div style="display: inline; font-style: italic; font: inherit;">2019.</div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">We are unable to estimate the full impact of COVID-<div style="display: inline; font-style: italic; font: inherit;">19</div> on our business and operations at this time. The extent of such impact will depend on future developments, which are highly uncertain, including when COVID-<div style="display: inline; font-style: italic; font: inherit;">19</div> can be controlled and abated and when and how the economy <div style="display: inline; font-style: italic; font: inherit;"> may </div>be reopened. The pandemic could cause us to experience higher credit losses in our loan portfolio, impairment of our goodwill, reduced demand for our products and services, or other negative impacts on our financial position, results of operations, and prospects.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">On <div style="display: inline; font-style: italic; font: inherit;"> March 27, 2020, </div>the President of the United States signed into law the Coronavirus Aid, Relief and Economic Security (“CARES”) Act in response to the coronavirus pandemic. This legislation aims at providing relief for individuals and businesses that have been negatively impacted by the coronavirus pandemic.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"> </div> <div style=" font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: left;"></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">The CARES Act includes a provision for the Company to opt out of applying the “troubled-debt restructuring” (“TDR”) accounting guidance in ASC <div style="display: inline; font-style: italic; font: inherit;">310</div>-<div style="display: inline; font-style: italic; font: inherit;">40</div> for certain loan modifications. Loan modifications made between <div style="display: inline; font-style: italic; font: inherit;"> March 1, 2020 </div>and the earlier of i) <div style="display: inline; font-style: italic; font: inherit;"> December 30, 2020 </div>or ii) <div style="display: inline; font-style: italic; font: inherit;">60</div> days after the President declares a termination of the COVID-<div style="display: inline; font-style: italic; font: inherit;">19</div> national emergency are eligible for this relief if the related loans were <div style="display: inline; font-style: italic; font: inherit;">not</div> more than <div style="display: inline; font-style: italic; font: inherit;">30</div> days past due as of <div style="display: inline; font-style: italic; font: inherit;"> December 31, 2019. </div>The Company has assessed which loans qualify for this treatment. The CARES Act also permits the Bank to continue to accrue interest on loans that have received deferral treatment as a result of the pandemic. In addition, on <div style="display: inline; font-style: italic; font: inherit;"> April 7, 2020, </div>a group of banking regulatory agencies issued a revised interagency statement that offers practical expedients for evaluating whether COVID-<div style="display: inline; font-style: italic; font: inherit;">19</div> loan modifications are TDRs.</div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"> </div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">On <div style="display: inline; font-style: italic; font: inherit;"> August 3, 2020, </div>the Federal Financial Institutions Council issued a joint statement, encouraging financial institutions to consider prudent accommodation options to mitigate losses for the borrower and financial institution beyond the initial accommodation period. The joint statement specifically encourages financial institutions to provide consumers with available options for repaying missed payments at the end of their accommodation to avoid delinquencies, as well as options for changes to terms to support sustainable and affordable payments for the long term. These considerations should also include prudent risk management practices at the financial institution based on the credit risk of the borrower. Patriot is actively working with its customers to address any further accommodation needs while carefully evaluating the associated credit risk of the borrowers.</div></div>
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	50000
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	124000
CY2019Q1	us-gaap	Capital Required For Capital Adequacy To Risk Weighted Assets CapitalRequiredForCapitalAdequacyToRiskWeightedAssets	0.105
CY2019Q3	us-gaap	Capital Required To Be Well Capitalized To Risk Weighted Assets CapitalRequiredToBeWellCapitalizedToRiskWeightedAssets	0.1
CY2020Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	49636000
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	39404000
CY2020Q3	us-gaap	Cash And Due From Banks CashAndDueFromBanks	3231000
CY2019Q4	us-gaap	Cash And Due From Banks CashAndDueFromBanks	2693000
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	39404000
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	66437000
CY2020Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	49636000
CY2019Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	50001000
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	10232000
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-16436000
CY2020Q2	us-gaap	Certain Loans Acquired In Transfer Not Accounted For As Debt Securities Accretable Yield CertainLoansAcquiredInTransferNotAccountedForAsDebtSecuritiesAccretableYield
CY2019Q2	us-gaap	Certain Loans Acquired In Transfer Not Accounted For As Debt Securities Accretable Yield CertainLoansAcquiredInTransferNotAccountedForAsDebtSecuritiesAccretableYield	201000
CY2019Q4	us-gaap	Certain Loans Acquired In Transfer Not Accounted For As Debt Securities Accretable Yield CertainLoansAcquiredInTransferNotAccountedForAsDebtSecuritiesAccretableYield	47000
CY2018Q4	us-gaap	Certain Loans Acquired In Transfer Not Accounted For As Debt Securities Accretable Yield CertainLoansAcquiredInTransferNotAccountedForAsDebtSecuritiesAccretableYield	792000
CY2020Q3	us-gaap	Certain Loans Acquired In Transfer Not Accounted For As Debt Securities Accretable Yield CertainLoansAcquiredInTransferNotAccountedForAsDebtSecuritiesAccretableYield
CY2019Q3	us-gaap	Certain Loans Acquired In Transfer Not Accounted For As Debt Securities Accretable Yield CertainLoansAcquiredInTransferNotAccountedForAsDebtSecuritiesAccretableYield	51000
CY2020Q3	us-gaap	Certain Loans Acquired In Transfer Not Accounted For As Debt Securities Accretable Yield Accretion CertainLoansAcquiredInTransferNotAccountedForAsDebtSecuritiesAccretableYieldAccretion
CY2019Q3	us-gaap	Certain Loans Acquired In Transfer Not Accounted For As Debt Securities Accretable Yield Accretion CertainLoansAcquiredInTransferNotAccountedForAsDebtSecuritiesAccretableYieldAccretion	9000
	us-gaap	Certain Loans Acquired In Transfer Not Accounted For As Debt Securities Accretable Yield Accretion CertainLoansAcquiredInTransferNotAccountedForAsDebtSecuritiesAccretableYieldAccretion	2000
	us-gaap	Certain Loans Acquired In Transfer Not Accounted For As Debt Securities Accretable Yield Accretion CertainLoansAcquiredInTransferNotAccountedForAsDebtSecuritiesAccretableYieldAccretion	43000
CY2020Q3	us-gaap	Certain Loans Acquired In Transfer Not Accounted For As Debt Securities Carrying Amount Net CertainLoansAcquiredInTransferNotAccountedForAsDebtSecuritiesCarryingAmountNet	0
CY2019Q4	us-gaap	Certain Loans Acquired In Transfer Not Accounted For As Debt Securities Carrying Amount Net CertainLoansAcquiredInTransferNotAccountedForAsDebtSecuritiesCarryingAmountNet	176000
CY2020Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2019Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2019Q3	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.01
	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.01
CY2020Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2019Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2020Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000
CY2019Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000
CY2020Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	4010782
CY2019Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	4004410
CY2020Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	3937041
CY2019Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	3930669
CY2020Q3	us-gaap	Common Stock Value CommonStockValue	106293000
CY2019Q4	us-gaap	Common Stock Value CommonStockValue	106170000
CY2020Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	323000
CY2019Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-131000
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-2580000
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-1196000
CY2020Q3	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger	18990000
CY2019Q3	us-gaap	Dividend Income Operating DividendIncomeOperating	112000
	us-gaap	Dividend Income Operating DividendIncomeOperating	313000
	us-gaap	Dividend Income Operating DividendIncomeOperating	344000
CY2019Q3	us-gaap	Dividends Common Stock DividendsCommonStock	39000
	us-gaap	Dividends Common Stock DividendsCommonStock	116000
CY2019Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger	17081000
CY2020Q3	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	945000
CY2019Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	886000
CY2020Q3	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months	10262000
CY2019Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months	7724000
CY2020Q3	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	173000
CY2019Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	62000
CY2020Q3	us-gaap	Debt Securities Available For Sale Unrealized Loss Position DebtSecuritiesAvailableForSaleUnrealizedLossPosition	29252000
CY2019Q4	us-gaap	Debt Securities Available For Sale Unrealized Loss Position DebtSecuritiesAvailableForSaleUnrealizedLossPosition	24805000
CY2020Q3	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss	1118000
CY2019Q4	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss	948000
CY2020Q3	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Number Of Positions DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions	19
CY2019Q4	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Number Of Positions DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions	15
CY2020Q3	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	12066000
CY2019Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	11133000
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-883000
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-667000
CY2020Q3	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	48000
	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	199000
CY2019Q3	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	53000
	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	195000
	us-gaap	Defined Contribution Plan Employer Matching Contribution Percent DefinedContributionPlanEmployerMatchingContributionPercent	0.5
	us-gaap	Defined Contribution Plan Maximum Annual Contributions Per Employee Percent DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent	0.06
CY2020Q3	us-gaap	Deposits Deposits	727431000
CY2019Q4	us-gaap	Deposits Deposits	769535000
CY2020Q3	us-gaap	Deposits Domestic DepositsDomestic	727431000
CY2019Q4	us-gaap	Deposits Domestic DepositsDomestic	769535000
CY2020Q3	us-gaap	Deposits Money Market Deposits DepositsMoneyMarketDeposits	142909000
CY2019Q4	us-gaap	Deposits Money Market Deposits DepositsMoneyMarketDeposits	99115000
CY2020Q3	us-gaap	Deposits Negotiable Order Of Withdrawal Now DepositsNegotiableOrderOfWithdrawalNOW	29518000
CY2019Q4	us-gaap	Deposits Negotiable Order Of Withdrawal Now DepositsNegotiableOrderOfWithdrawalNOW	26864000
CY2020Q3	us-gaap	Deposits Savings Deposits DepositsSavingsDeposits	91169000
CY2019Q4	us-gaap	Deposits Savings Deposits DepositsSavingsDeposits	64020000
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1144000
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	1201000
CY2020Q3	us-gaap	Deteriorated Loans Transferred In Debt Securities Accreditable Yield Period Increase Decrease DeterioratedLoansTransferredInDebtSecuritiesAccreditableYieldPeriodIncreaseDecrease	0
	us-gaap	Deteriorated Loans Transferred In Debt Securities Accreditable Yield Period Increase Decrease DeterioratedLoansTransferredInDebtSecuritiesAccreditableYieldPeriodIncreaseDecrease	2000
CY2019Q3	us-gaap	Deteriorated Loans Transferred In Debt Securities Accreditable Yield Period Increase Decrease DeterioratedLoansTransferredInDebtSecuritiesAccreditableYieldPeriodIncreaseDecrease	9000
	us-gaap	Deteriorated Loans Transferred In Debt Securities Accreditable Yield Period Increase Decrease DeterioratedLoansTransferredInDebtSecuritiesAccreditableYieldPeriodIncreaseDecrease	43000
CY2020Q3	us-gaap	Dividend Income Operating DividendIncomeOperating	85000
CY2020Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.02
CY2019Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.01
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.62
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.33
CY2020Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.02
CY2019Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.01
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.62
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.33
	us-gaap	Fair Value Of Assets Acquired FairValueOfAssetsAcquired	50000
	us-gaap	Fair Value Of Assets Acquired FairValueOfAssetsAcquired	124000
CY2020Q3	us-gaap	Federal Home Loan Bank Advances Long Term FederalHomeLoanBankAdvancesLongTerm	90000000
CY2019Q4	us-gaap	Federal Home Loan Bank Advances Long Term FederalHomeLoanBankAdvancesLongTerm	100000000
CY2020Q3	us-gaap	Federal Home Loan Bank Stock FederalHomeLoanBankStock	4503000
CY2019Q4	us-gaap	Federal Home Loan Bank Stock FederalHomeLoanBankStock	4477000
CY2020Q3	us-gaap	Federal Reserve Bank Stock FederalReserveBankStock	2783000
CY2019Q4	us-gaap	Federal Reserve Bank Stock FederalReserveBankStock	2897000
CY2020Q3	us-gaap	Financing Receivable Modifications Number Of Contracts2 FinancingReceivableModificationsNumberOfContracts2	0
CY2019Q3	us-gaap	Financing Receivable Modifications Number Of Contracts2 FinancingReceivableModificationsNumberOfContracts2	0
	us-gaap	Financing Receivable Modifications Number Of Contracts2 FinancingReceivableModificationsNumberOfContracts2	3
	us-gaap	Financing Receivable Modifications Number Of Contracts2 FinancingReceivableModificationsNumberOfContracts2	2
	us-gaap	Financing Receivable Modifications Post Modification Recorded Investment2 FinancingReceivableModificationsPostModificationRecordedInvestment2	177000
	us-gaap	Financing Receivable Modifications Post Modification Recorded Investment2 FinancingReceivableModificationsPostModificationRecordedInvestment2	8911000
CY2020Q3	us-gaap	Financing Receivable Modifications Post Modification Recorded Investment2 FinancingReceivableModificationsPostModificationRecordedInvestment2
CY2019Q3	us-gaap	Financing Receivable Modifications Post Modification Recorded Investment2 FinancingReceivableModificationsPostModificationRecordedInvestment2
	us-gaap	Financing Receivable Modifications Pre Modification Recorded Investment2 FinancingReceivableModificationsPreModificationRecordedInvestment2	178000
	us-gaap	Financing Receivable Modifications Pre Modification Recorded Investment2 FinancingReceivableModificationsPreModificationRecordedInvestment2	8912000
CY2020Q3	us-gaap	Financing Receivable Modifications Recorded Investment FinancingReceivableModificationsRecordedInvestment	11108000
CY2019Q4	us-gaap	Financing Receivable Modifications Recorded Investment FinancingReceivableModificationsRecordedInvestment	10953000
CY2020Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	567000
CY2019Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	623000
CY2020Q3	us-gaap	Gain Loss On Sales Of Loans Net GainLossOnSalesOfLoansNet	380000
CY2019Q3	us-gaap	Gain Loss On Sales Of Loans Net GainLossOnSalesOfLoansNet	188000
	us-gaap	Gain Loss On Sales Of Loans Net GainLossOnSalesOfLoansNet	464000
	us-gaap	Gain Loss On Sales Of Loans Net GainLossOnSalesOfLoansNet	864000
	us-gaap	Gains Losses On Sales Of Other Real Estate GainsLossesOnSalesOfOtherRealEstate	-21000
	us-gaap	Gains Losses On Sales Of Other Real Estate GainsLossesOnSalesOfOtherRealEstate	-94000
CY2020Q2	us-gaap	Goodwill Goodwill	1107000
CY2019Q2	us-gaap	Goodwill Goodwill	1107000
CY2019Q4	us-gaap	Goodwill Goodwill	1107000
CY2018Q4	us-gaap	Goodwill Goodwill	1728000
CY2020Q3	us-gaap	Goodwill Goodwill	1107000
CY2019Q3	us-gaap	Goodwill Goodwill	1107000
CY2020Q3	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0
CY2020Q3	us-gaap	Goodwill Purchase Accounting Adjustments GoodwillPurchaseAccountingAdjustments
CY2019Q3	us-gaap	Goodwill Purchase Accounting Adjustments GoodwillPurchaseAccountingAdjustments
	us-gaap	Goodwill Purchase Accounting Adjustments GoodwillPurchaseAccountingAdjustments
	us-gaap	Goodwill Purchase Accounting Adjustments GoodwillPurchaseAccountingAdjustments	-621000
CY2020Q3	us-gaap	Impaired Financing Receivable Average Recorded Investment ImpairedFinancingReceivableAverageRecordedInvestment	22757000
CY2019Q3	us-gaap	Impaired Financing Receivable Average Recorded Investment ImpairedFinancingReceivableAverageRecordedInvestment	20909000
	us-gaap	Impaired Financing Receivable Average Recorded Investment ImpairedFinancingReceivableAverageRecordedInvestment	21301000
	us-gaap	Impaired Financing Receivable Average Recorded Investment ImpairedFinancingReceivableAverageRecordedInvestment	23480000
CY2020Q3	us-gaap	Impaired Financing Receivable Interest Income Accrual Method ImpairedFinancingReceivableInterestIncomeAccrualMethod	39000
CY2019Q3	us-gaap	Impaired Financing Receivable Interest Income Accrual Method ImpairedFinancingReceivableInterestIncomeAccrualMethod	252000
	us-gaap	Impaired Financing Receivable Interest Income Accrual Method ImpairedFinancingReceivableInterestIncomeAccrualMethod	157000
	us-gaap	Impaired Financing Receivable Interest Income Accrual Method ImpairedFinancingReceivableInterestIncomeAccrualMethod	709000
CY2020Q3	us-gaap	Impaired Financing Receivable Recorded Investment ImpairedFinancingReceivableRecordedInvestment	22200000
CY2019Q4	us-gaap	Impaired Financing Receivable Recorded Investment ImpairedFinancingReceivableRecordedInvestment	19600000
CY2020Q3	us-gaap	Impaired Financing Receivable Related Allowance ImpairedFinancingReceivableRelatedAllowance	1600000
CY2019Q4	us-gaap	Impaired Financing Receivable Related Allowance ImpairedFinancingReceivableRelatedAllowance	1500000
CY2020Q3	us-gaap	Impaired Financing Receivable With No Related Allowance Average Recorded Investment ImpairedFinancingReceivableWithNoRelatedAllowanceAverageRecordedInvestment	13653000
CY2019Q3	us-gaap	Impaired Financing Receivable With No Related Allowance Average Recorded Investment ImpairedFinancingReceivableWithNoRelatedAllowanceAverageRecordedInvestment	20909000
	us-gaap	Impaired Financing Receivable With No Related Allowance Average Recorded Investment ImpairedFinancingReceivableWithNoRelatedAllowanceAverageRecordedInvestment	12342000
	us-gaap	Impaired Financing Receivable With No Related Allowance Average Recorded Investment ImpairedFinancingReceivableWithNoRelatedAllowanceAverageRecordedInvestment	19717000
CY2020Q3	us-gaap	Impaired Financing Receivable With No Related Allowance Interest Income Accrual Method ImpairedFinancingReceivableWithNoRelatedAllowanceInterestIncomeAccrualMethod	37000
CY2019Q3	us-gaap	Impaired Financing Receivable With No Related Allowance Interest Income Accrual Method ImpairedFinancingReceivableWithNoRelatedAllowanceInterestIncomeAccrualMethod	252000
	us-gaap	Impaired Financing Receivable With No Related Allowance Interest Income Accrual Method ImpairedFinancingReceivableWithNoRelatedAllowanceInterestIncomeAccrualMethod	114000
	us-gaap	Impaired Financing Receivable With No Related Allowance Interest Income Accrual Method ImpairedFinancingReceivableWithNoRelatedAllowanceInterestIncomeAccrualMethod	709000
CY2020Q3	us-gaap	Impaired Financing Receivable With Related Allowance Average Recorded Investment ImpairedFinancingReceivableWithRelatedAllowanceAverageRecordedInvestment	9104000
CY2019Q3	us-gaap	Impaired Financing Receivable With Related Allowance Average Recorded Investment ImpairedFinancingReceivableWithRelatedAllowanceAverageRecordedInvestment
	us-gaap	Impaired Financing Receivable With Related Allowance Average Recorded Investment ImpairedFinancingReceivableWithRelatedAllowanceAverageRecordedInvestment	8959000
	us-gaap	Impaired Financing Receivable With Related Allowance Average Recorded Investment ImpairedFinancingReceivableWithRelatedAllowanceAverageRecordedInvestment	3763000
CY2020Q3	us-gaap	Impaired Financing Receivable With Related Allowance Interest Income Accrual Method ImpairedFinancingReceivableWithRelatedAllowanceInterestIncomeAccrualMethod	2000
CY2019Q3	us-gaap	Impaired Financing Receivable With Related Allowance Interest Income Accrual Method ImpairedFinancingReceivableWithRelatedAllowanceInterestIncomeAccrualMethod
	us-gaap	Impaired Financing Receivable With Related Allowance Interest Income Accrual Method ImpairedFinancingReceivableWithRelatedAllowanceInterestIncomeAccrualMethod	43000
	us-gaap	Impaired Financing Receivable With Related Allowance Interest Income Accrual Method ImpairedFinancingReceivableWithRelatedAllowanceInterestIncomeAccrualMethod
CY2020Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-93000
CY2019Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	35000
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-3248000
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	-1761000
CY2020Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-6000
CY2019Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	8000
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-811000
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-456000
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	-193000
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	22000
	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-1465000
	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	700000
	us-gaap	Increase Decrease In Advance Payments By Borrowers For Taxes And Insurance IncreaseDecreaseInAdvancePaymentsByBorrowersForTaxesAndInsurance	-1189000
	us-gaap	Increase Decrease In Advance Payments By Borrowers For Taxes And Insurance IncreaseDecreaseInAdvancePaymentsByBorrowersForTaxesAndInsurance	-744000
	us-gaap	Increase Decrease In Deposits IncreaseDecreaseInDeposits	-92102000
	us-gaap	Increase Decrease In Deposits IncreaseDecreaseInDeposits	18775000
	us-gaap	Increase Decrease In Interest And Dividends Receivable IncreaseDecreaseInInterestAndDividendsReceivable	3231000
	us-gaap	Increase Decrease In Interest And Dividends Receivable IncreaseDecreaseInInterestAndDividendsReceivable	-228000
	us-gaap	Increase Decrease In Loans From Other Federal Home Loan Banks IncreaseDecreaseInLoansFromOtherFederalHomeLoanBanks	-10000000
	us-gaap	Increase Decrease In Loans From Other Federal Home Loan Banks IncreaseDecreaseInLoansFromOtherFederalHomeLoanBanks
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	674000
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	1779000
CY2020Q3	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
CY2019Q3	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
CY2020Q3	us-gaap	Information Technology And Data Processing InformationTechnologyAndDataProcessing	433000
CY2019Q3	us-gaap	Information Technology And Data Processing InformationTechnologyAndDataProcessing	357000
	us-gaap	Information Technology And Data Processing InformationTechnologyAndDataProcessing	1194000
	us-gaap	Interest Income Operating InterestIncomeOperating	1207000
CY2020Q3	us-gaap	Interest Income Other Domestic Deposits InterestIncomeOtherDomesticDeposits	28000
CY2019Q3	us-gaap	Interest Income Other Domestic Deposits InterestIncomeOtherDomesticDeposits	225000
	us-gaap	Interest Income Other Domestic Deposits InterestIncomeOtherDomesticDeposits	187000
	us-gaap	Interest Income Other Domestic Deposits InterestIncomeOtherDomesticDeposits	795000
	us-gaap	Interest Paid Net InterestPaidNet	12237000
	us-gaap	Interest Paid Net InterestPaidNet	12996000
CY2020Q3	us-gaap	Investments Investments	52273000
	us-gaap	Interest Expense Subordinated Notes And Debentures InterestExpenseSubordinatedNotesAndDebentures	845000
CY2020Q3	us-gaap	Interest Income Expense After Provision For Loan Loss InterestIncomeExpenseAfterProvisionForLoanLoss	5821000
CY2019Q3	us-gaap	Interest Income Expense After Provision For Loan Loss InterestIncomeExpenseAfterProvisionForLoanLoss	6143000
	us-gaap	Interest Income Expense After Provision For Loan Loss InterestIncomeExpenseAfterProvisionForLoanLoss	16117000
	us-gaap	Interest Income Expense After Provision For Loan Loss InterestIncomeExpenseAfterProvisionForLoanLoss	16019000
CY2020Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	5906000
CY2019Q3	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	6243000
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	17916000
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	19221000
CY2020Q3	us-gaap	Interest Income Operating InterestIncomeOperating	340000
CY2019Q3	us-gaap	Interest Income Operating InterestIncomeOperating	430000
	us-gaap	Interest Income Operating InterestIncomeOperating	1134000
CY2019Q4	us-gaap	Investments Investments	52767000
	us-gaap	Information Technology And Data Processing InformationTechnologyAndDataProcessing	1088000
CY2020Q3	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	9031000
CY2019Q3	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	11012000
	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	29356000
	us-gaap	Interest And Dividend Income Operating InterestAndDividendIncomeOperating	32691000
CY2020Q3	us-gaap	Interest And Fee Income Loans And Leases InterestAndFeeIncomeLoansAndLeases	8578000
CY2019Q3	us-gaap	Interest And Fee Income Loans And Leases InterestAndFeeIncomeLoansAndLeases	10245000
	us-gaap	Interest And Fee Income Loans And Leases InterestAndFeeIncomeLoansAndLeases	27722000
	us-gaap	Interest And Fee Income Loans And Leases InterestAndFeeIncomeLoansAndLeases	30345000
CY2020Q3	us-gaap	Interest Bearing Deposit Liabilities InterestBearingDepositLiabilities	565560000
CY2019Q4	us-gaap	Interest Bearing Deposit Liabilities InterestBearingDepositLiabilities	681400000
CY2020Q3	us-gaap	Interest Bearing Deposit Liabilities Domestic InterestBearingDepositLiabilitiesDomestic	565560000
CY2019Q4	us-gaap	Interest Bearing Deposit Liabilities Domestic InterestBearingDepositLiabilitiesDomestic	681400000
CY2020Q3	us-gaap	Interest Bearing Deposits In Banks InterestBearingDepositsInBanks	46405000
CY2019Q4	us-gaap	Interest Bearing Deposits In Banks InterestBearingDepositsInBanks	36711000
CY2020Q3	us-gaap	Interest Bearing Domestic Deposit Brokered InterestBearingDomesticDepositBrokered	90995000
CY2019Q4	us-gaap	Interest Bearing Domestic Deposit Brokered InterestBearingDomesticDepositBrokered	229909000
CY2020Q3	us-gaap	Interest Expense InterestExpense	3125000
CY2019Q3	us-gaap	Interest Expense InterestExpense	4769000
	us-gaap	Interest Expense InterestExpense	11440000
	us-gaap	Interest Expense InterestExpense	13470000
CY2020Q3	us-gaap	Interest Expense Deposits InterestExpenseDeposits	2028000
CY2019Q3	us-gaap	Interest Expense Deposits InterestExpenseDeposits	3655000
	us-gaap	Interest Expense Deposits InterestExpenseDeposits	8020000
	us-gaap	Interest Expense Deposits InterestExpenseDeposits	10452000
CY2020Q3	us-gaap	Interest Expense Federal Home Loan Bank And Federal Reserve Bank Advances Long Term InterestExpenseFederalHomeLoanBankAndFederalReserveBankAdvancesLongTerm	628000
CY2019Q3	us-gaap	Interest Expense Federal Home Loan Bank And Federal Reserve Bank Advances Long Term InterestExpenseFederalHomeLoanBankAndFederalReserveBankAdvancesLongTerm	602000
	us-gaap	Interest Expense Federal Home Loan Bank And Federal Reserve Bank Advances Long Term InterestExpenseFederalHomeLoanBankAndFederalReserveBankAdvancesLongTerm	1963000
	us-gaap	Interest Expense Federal Home Loan Bank And Federal Reserve Bank Advances Long Term InterestExpenseFederalHomeLoanBankAndFederalReserveBankAdvancesLongTerm	1467000
CY2020Q3	us-gaap	Interest Expense Subordinated Notes And Debentures InterestExpenseSubordinatedNotesAndDebentures	235000
CY2019Q3	us-gaap	Interest Expense Subordinated Notes And Debentures InterestExpenseSubordinatedNotesAndDebentures	277000
	us-gaap	Interest Expense Subordinated Notes And Debentures InterestExpenseSubordinatedNotesAndDebentures	756000
CY2020Q3	us-gaap	Junior Subordinated Debenture Owed To Unconsolidated Subsidiary Trust JuniorSubordinatedDebentureOwedToUnconsolidatedSubsidiaryTrust	8108000
CY2019Q4	us-gaap	Junior Subordinated Debenture Owed To Unconsolidated Subsidiary Trust JuniorSubordinatedDebentureOwedToUnconsolidatedSubsidiaryTrust	8102000
CY2020Q3	us-gaap	Labor And Related Expense LaborAndRelatedExpense	3460000
CY2019Q3	us-gaap	Labor And Related Expense LaborAndRelatedExpense	3480000
	us-gaap	Labor And Related Expense LaborAndRelatedExpense	10966000
	us-gaap	Labor And Related Expense LaborAndRelatedExpense	10272000
CY2020Q3	us-gaap	Liabilities Liabilities	858392000
CY2019Q4	us-gaap	Liabilities Liabilities	912842000
CY2020Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	922929000
CY2019Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	979836000
CY2020Q3	us-gaap	Loan Processing Fee LoanProcessingFee	75000
CY2019Q3	us-gaap	Loan Processing Fee LoanProcessingFee	44000
	us-gaap	Loan Processing Fee LoanProcessingFee	135000
	us-gaap	Loan Processing Fee LoanProcessingFee	101000
CY2020Q2	us-gaap	Loans And Leases Receivable Allowance LoansAndLeasesReceivableAllowance	11148000
CY2020Q3	us-gaap	Loans And Leases Receivable Allowance LoansAndLeasesReceivableAllowance	11171000
CY2019Q2	us-gaap	Loans And Leases Receivable Allowance LoansAndLeasesReceivableAllowance	8458000
CY2019Q3	us-gaap	Loans And Leases Receivable Allowance LoansAndLeasesReceivableAllowance	8405000
CY2019Q4	us-gaap	Loans And Leases Receivable Allowance LoansAndLeasesReceivableAllowance	10115000
CY2018Q4	us-gaap	Loans And Leases Receivable Allowance LoansAndLeasesReceivableAllowance	7609000
CY2020Q3	us-gaap	Loans And Leases Receivable Impaired Commitment To Lend LoansAndLeasesReceivableImpairedCommitmentToLend	0
CY2019Q4	us-gaap	Loans And Leases Receivable Impaired Commitment To Lend LoansAndLeasesReceivableImpairedCommitmentToLend	0
CY2020Q3	us-gaap	Loans And Leases Receivable Impaired Interest Lost On Nonaccrual Loans LoansAndLeasesReceivableImpairedInterestLostOnNonaccrualLoans	216000
	us-gaap	Loans And Leases Receivable Impaired Interest Lost On Nonaccrual Loans LoansAndLeasesReceivableImpairedInterestLostOnNonaccrualLoans	691000
CY2019Q3	us-gaap	Loans And Leases Receivable Impaired Interest Lost On Nonaccrual Loans LoansAndLeasesReceivableImpairedInterestLostOnNonaccrualLoans	134000
	us-gaap	Loans And Leases Receivable Impaired Interest Lost On Nonaccrual Loans LoansAndLeasesReceivableImpairedInterestLostOnNonaccrualLoans	271000
CY2020Q3	us-gaap	Loans Receivable Held For Sale Amount LoansReceivableHeldForSaleAmount	6824000
CY2019Q4	us-gaap	Loans Receivable Held For Sale Amount LoansReceivableHeldForSaleAmount	15282000
CY2020Q3	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	107000
CY2019Q3	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	63000
	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	377000
	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	255000
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-53442000
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	17769000
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	64427000
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-32770000
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-753000
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1435000
	us-gaap	Net Income Loss NetIncomeLoss	-2437000
	us-gaap	Net Income Loss NetIncomeLoss	-1305000
CY2020Q3	us-gaap	Net Income Loss NetIncomeLoss	-87000
CY2019Q3	us-gaap	Net Income Loss NetIncomeLoss	27000
CY2020Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-87000
CY2019Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	27000
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-2437000
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-1305000
CY2020Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-87000
CY2019Q3	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	27000
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-2437000
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-1305000
CY2020Q3	us-gaap	Noninterest Bearing Deposit Liabilities NoninterestBearingDepositLiabilities	161871000
CY2019Q4	us-gaap	Noninterest Bearing Deposit Liabilities NoninterestBearingDepositLiabilities	88135000
CY2020Q3	us-gaap	Noninterest Bearing Deposit Liabilities Domestic NoninterestBearingDepositLiabilitiesDomestic	161871000
CY2019Q4	us-gaap	Noninterest Bearing Deposit Liabilities Domestic NoninterestBearingDepositLiabilitiesDomestic	88135000
CY2020Q3	us-gaap	Noninterest Expense NoninterestExpense	6618000
CY2019Q3	us-gaap	Noninterest Expense NoninterestExpense	6679000
	us-gaap	Noninterest Expense NoninterestExpense	20879000
	us-gaap	Noninterest Expense NoninterestExpense	19855000
CY2020Q3	us-gaap	Noninterest Income NoninterestIncome	704000
CY2019Q3	us-gaap	Noninterest Income NoninterestIncome	571000
	us-gaap	Noninterest Income NoninterestIncome	1514000
	us-gaap	Noninterest Income NoninterestIncome	2075000
CY2020Q3	us-gaap	Noninterest Income Other NoninterestIncomeOther	66000
CY2019Q3	us-gaap	Noninterest Income Other NoninterestIncomeOther	91000
	us-gaap	Noninterest Income Other NoninterestIncomeOther	257000
	us-gaap	Noninterest Income Other NoninterestIncomeOther	312000
CY2020Q3	us-gaap	Notes Payable To Bank NotesPayableToBank	1044000
CY2019Q4	us-gaap	Notes Payable To Bank NotesPayableToBank	1193000
CY2020Q3	us-gaap	Notes Receivable Net NotesReceivableNet	740127000
CY2019Q4	us-gaap	Notes Receivable Net NotesReceivableNet	802049000
CY2020Q3	us-gaap	Occupancy Net OccupancyNet	810000
CY2019Q3	us-gaap	Occupancy Net OccupancyNet	937000
	us-gaap	Occupancy Net OccupancyNet	2680000
	us-gaap	Occupancy Net OccupancyNet	2598000
CY2020Q3	us-gaap	Operating Leases Income Statement Lease Revenue OperatingLeasesIncomeStatementLeaseRevenue	131000
CY2019Q3	us-gaap	Operating Leases Income Statement Lease Revenue OperatingLeasesIncomeStatementLeaseRevenue	137000
	us-gaap	Operating Leases Income Statement Lease Revenue OperatingLeasesIncomeStatementLeaseRevenue	393000
	us-gaap	Operating Leases Income Statement Lease Revenue OperatingLeasesIncomeStatementLeaseRevenue	459000
CY2020Q3	us-gaap	Other Accrued Liabilities Current And Noncurrent OtherAccruedLiabilitiesCurrentAndNoncurrent	7634000
CY2019Q4	us-gaap	Other Accrued Liabilities Current And Noncurrent OtherAccruedLiabilitiesCurrentAndNoncurrent	8726000
CY2020Q3	us-gaap	Other Assets OtherAssets	10623000
CY2019Q4	us-gaap	Other Assets OtherAssets	9526000
CY2020Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	410000
CY2019Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-158000
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-143000
	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	109000
CY2020Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	553000
CY2019Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	-215000
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	-193000
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax	132000
CY2020Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	143000
CY2019Q3	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	-57000
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	-50000
	us-gaap	Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Tax OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax	23000
CY2020Q3	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	560000
CY2019Q3	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	530000
	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	1491000
	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	1626000
CY2020Q3	us-gaap	Other Investments OtherInvestments	4450000
CY2019Q4	us-gaap	Other Investments OtherInvestments	4450000
CY2020Q3	us-gaap	Other Real Estate OtherRealEstate	1954000
CY2019Q4	us-gaap	Other Real Estate OtherRealEstate	2400000
	us-gaap	Other Than Temporary Impairment Loss Debt Securities Available For Sale OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale	0
	us-gaap	Other Than Temporary Impairment Losses Investments Availableforsale Securities OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities	0
	us-gaap	Payments For Proceeds From Federal Home Loan Bank Stock PaymentsForProceedsFromFederalHomeLoanBankStock	26000
	us-gaap	Payments For Proceeds From Federal Home Loan Bank Stock PaymentsForProceedsFromFederalHomeLoanBankStock	-451000
	us-gaap	Payments For Proceeds From Federal Reserve Bank Stock PaymentsForProceedsFromFederalReserveBankStock	-114000
	us-gaap	Payments For Proceeds From Federal Reserve Bank Stock PaymentsForProceedsFromFederalReserveBankStock	23000
CY2019Q3	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	39000
	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	116000
	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock
	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	6541000
	us-gaap	Payments To Acquire Available For Sale Securities PaymentsToAcquireAvailableForSaleSecurities	12997000
	us-gaap	Payments To Acquire Loans Receivable PaymentsToAcquireLoansReceivable	31525000
	us-gaap	Payments To Acquire Loans Receivable PaymentsToAcquireLoansReceivable	28213000
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	158000
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	525000
CY2020Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0
CY2019Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0
CY2020Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000
CY2019Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000
CY2020Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2019Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2020Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2019Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2020Q3	us-gaap	Preferred Stock Value PreferredStockValue	0
CY2019Q4	us-gaap	Preferred Stock Value PreferredStockValue	0
	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	0
	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	0
	us-gaap	Proceeds From Sale Of Other Loans Held For Sale ProceedsFromSaleOfOtherLoansHeldForSale	6096000
	us-gaap	Proceeds From Sale Of Other Loans Held For Sale ProceedsFromSaleOfOtherLoansHeldForSale	11969000
	us-gaap	Proceeds From Sale Of Other Real Estate ProceedsFromSaleOfOtherRealEstate	425000
	us-gaap	Proceeds From Sale Of Other Real Estate ProceedsFromSaleOfOtherRealEstate	897000
CY2020Q3	us-gaap	Professional And Contract Services Expense ProfessionalAndContractServicesExpense	627000
CY2019Q3	us-gaap	Professional And Contract Services Expense ProfessionalAndContractServicesExpense	721000
	us-gaap	Professional And Contract Services Expense ProfessionalAndContractServicesExpense	2137000
	us-gaap	Professional And Contract Services Expense ProfessionalAndContractServicesExpense	2233000
CY2020Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	33632000
CY2019Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	34568000
CY2020Q3	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	85000
CY2019Q3	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	100000
	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	1799000
	us-gaap	Provision For Loan And Lease Losses ProvisionForLoanAndLeaseLosses	3202000
	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	1799000
	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	3202000
CY2020Q3	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	85000
CY2019Q3	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	100000
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	149000
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	146000
CY2020Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-41210000
CY2019Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-38773000
CY2020Q3	us-gaap	Senior Notes SeniorNotes	11909000
CY2019Q4	us-gaap	Senior Notes SeniorNotes	11853000
CY2020Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3935898
CY2020Q3	us-gaap	Servicing Asset ServicingAsset	301000
CY2020Q2	us-gaap	Servicing Asset At Amortized Value ServicingAssetAtAmortizedValue	221000
CY2019Q2	us-gaap	Servicing Asset At Amortized Value ServicingAssetAtAmortizedValue	156000
CY2019Q4	us-gaap	Servicing Asset At Amortized Value ServicingAssetAtAmortizedValue	201000
CY2018Q4	us-gaap	Servicing Asset At Amortized Value ServicingAssetAtAmortizedValue	37000
CY2020Q3	us-gaap	Servicing Asset At Amortized Value ServicingAssetAtAmortizedValue	301000
CY2019Q3	us-gaap	Servicing Asset At Amortized Value ServicingAssetAtAmortizedValue	196000
CY2020Q3	us-gaap	Servicing Asset At Amortized Value Additions ServicingAssetAtAmortizedValueAdditions	86000
CY2019Q3	us-gaap	Servicing Asset At Amortized Value Additions ServicingAssetAtAmortizedValueAdditions	44000
	us-gaap	Servicing Asset At Amortized Value Additions ServicingAssetAtAmortizedValueAdditions	115000
	us-gaap	Servicing Asset At Amortized Value Additions ServicingAssetAtAmortizedValueAdditions	169000
CY2020Q3	us-gaap	Servicing Asset At Amortized Value Amortization1 ServicingAssetAtAmortizedValueAmortization1	6000
CY2019Q3	us-gaap	Servicing Asset At Amortized Value Amortization1 ServicingAssetAtAmortizedValueAmortization1	4000
	us-gaap	Servicing Asset At Amortized Value Amortization1 ServicingAssetAtAmortizedValueAmortization1	15000
	us-gaap	Servicing Asset At Amortized Value Amortization1 ServicingAssetAtAmortizedValueAmortization1	10000
CY2020Q3	us-gaap	Servicing Asset At Fair Value Amount ServicingAssetAtFairValueAmount	362000
	us-gaap	Share Based Compensation ShareBasedCompensation	123000
	us-gaap	Share Based Compensation ShareBasedCompensation	162000
CY2020Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	42000
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	123000
CY2019Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	59000
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	162000
CY2020Q3	us-gaap	Stockholders Equity StockholdersEquity	64537000
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	66994000
CY2020Q2	us-gaap	Stockholders Equity StockholdersEquity	64172000
CY2019Q2	us-gaap	Stockholders Equity StockholdersEquity	68290000
CY2019Q3	us-gaap	Stockholders Equity StockholdersEquity	68179000
CY2018Q4	us-gaap	Stockholders Equity StockholdersEquity	69340000
CY2020Q3	us-gaap	Subordinated Debt SubordinatedDebt	9774000
CY2019Q4	us-gaap	Subordinated Debt SubordinatedDebt	9752000
CY2020Q3	us-gaap	Tier One Leverage Capital Required To Be Well Capitalized To Average Assets TierOneLeverageCapitalRequiredToBeWellCapitalizedToAverageAssets	0.09
CY2020Q3	us-gaap	Tier One Risk Based Capital Required To Be Well Capitalized To Risk Weighted Assets TierOneRiskBasedCapitalRequiredToBeWellCapitalizedToRiskWeightedAssets	0.08
CY2020Q3	us-gaap	Time Deposit Maturities Remainder Of Fiscal Year TimeDepositMaturitiesRemainderOfFiscalYear	266497000
CY2020Q3	us-gaap	Time Deposit Maturities Year Four TimeDepositMaturitiesYearFour	997000
CY2020Q3	us-gaap	Time Deposit Maturities Year One TimeDepositMaturitiesYearOne	30858000
CY2020Q3	us-gaap	Time Deposit Maturities Year Three TimeDepositMaturitiesYearThree	1163000
CY2020Q3	us-gaap	Time Deposit Maturities Year Two TimeDepositMaturitiesYearTwo	2449000
CY2020Q3	us-gaap	Time Deposits TimeDeposits	301964000
CY2020Q3	us-gaap	Time Deposits At Or Above Fdic Insurance Limit TimeDepositsAtOrAboveFDICInsuranceLimit	50359000
CY2019Q4	us-gaap	Time Deposits At Or Above Fdic Insurance Limit TimeDepositsAtOrAboveFDICInsuranceLimit	67550000
	us-gaap	Transfer Of Portfolio Loans And Leases To Held For Sale1 TransferOfPortfolioLoansAndLeasesToHeldForSale1	5022000
	us-gaap	Transfer Of Portfolio Loans And Leases To Held For Sale1 TransferOfPortfolioLoansAndLeasesToHeldForSale1
	us-gaap	Transfer To Other Real Estate TransferToOtherRealEstate
	us-gaap	Transfer To Other Real Estate TransferToOtherRealEstate	446000
CY2020Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3935898
CY2019Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3922783
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3934138
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	3920678
CY2019Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3922783
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3934138
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3920678

Files In Submission

Name	View Source	Status
0001437749-20-023808-index-headers.html	Edgar Link	pending
0001437749-20-023808-index.html	Edgar Link	pending
0001437749-20-023808.txt	Edgar Link	pending
0001437749-20-023808-xbrl.zip	Edgar Link	pending
ex_212686.htm	Edgar Link	pending
ex_212687.htm	Edgar Link	pending
ex_212688.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
pnbk-20200930.xml	Edgar Link	completed
pnbk-20200930.xsd	Edgar Link	pending
pnbk-20200930_cal.xml	Edgar Link	unprocessable
pnbk-20200930_def.xml	Edgar Link	unprocessable
pnbk-20200930_lab.xml	Edgar Link	unprocessable
pnbk-20200930_pre.xml	Edgar Link	unprocessable
pnbk20200930_10q.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$PNBK
PATRIOT NATIONAL BANCORP INC Stock $pnbk

2020 Q3 Form 10-Q Financial Statement

#000143774920023808 Filed on November 13, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PNBK PATRIOT NATIONAL BANCORP INC Stock $pnbk

2020 Q3 Form 10-Q Financial Statement

#000143774920023808 Filed on November 13, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PNBK
PATRIOT NATIONAL BANCORP INC Stock $pnbk